Australia markets closed

Horizon Therapeutics Public Limited Company (HZNP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
75.39+3.17 (+4.39%)
As of 10:45AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close72.22
Open71.79
Bid75.52 x 1200
Ask75.43 x 900
Day's range71.75 - 76.44
52-week range23.81 - 77.45
Volume4,906,967
Avg. volume2,609,996
Market cap14.774B
Beta (5Y monthly)1.23
PE ratio (TTM)29.58
EPS (TTM)2.55
Earnings date05 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est91.20
  • Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares
    Business Wire

    Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares

    Horizon Therapeutics plc (Nasdaq: HZNP) today announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a price to the public of $71.00 per share. The net proceeds to the Company from this offering are expected to be approximately $798.9 million, after deducting underwriting discounts and other estimated offering expenses payable by the Company. The Company has also granted the underwriters a 30-day option to purchase up to an additional 1,770,000 ordinary shares. The offering is expected to close on or about August 11, 2020, subject to customary closing conditions.

  • Horizon Therapeutics Named 2020 Top Workplace for Millennials by Fortune
    Business Wire

    Horizon Therapeutics Named 2020 Top Workplace for Millennials by Fortune

    Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the 2020 Fortune Best Workplaces for Millennials™ list. Horizon ranked 7th among 25 companies in the small and medium company category in its first year on the list.

  • Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares
    Business Wire

    Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares

    Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $105,000,000 of ordinary shares in the public offering.